Geron
GERN
#6280
Rank
โ‚น75.12 B
Marketcap
โ‚น117.69
Share price
3.15%
Change (1 day)
-65.08%
Change (1 year)

Revenue for Geron (GERN)

Revenue in 2025 (TTM): โ‚น15.86 Billion

According to Geron's latest financial reports the company's current revenue (TTM ) is โ‚น16.47 Billion. In 2024 the company made a revenue of โ‚น6.60 Billion an increase over the revenue in the year 2023 that were of โ‚น19.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Geron from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น15.86 B140.14%
2024 โ‚น6.60 B33377.25%
2023 โ‚น19.72 M-60%
2022 โ‚น49.31 M-52.43%
2021 โ‚น0.10 B460.36%
2020 โ‚น18.5 M-43.59%
2019 โ‚น32.8 M-55.99%
2018 โ‚น74.53 M9.61%
2017 โ‚น68 M-83.76%
2016 โ‚น0.41 B-82.68%
2015 โ‚น2.41 B3207.62%
2014 โ‚น73.07 M-7.81%
2013 โ‚น79.26 M-46.56%
2012 โ‚น0.14 B15.01%
2011 โ‚น0.12 B-19.22%
2010 โ‚น0.15 B99.36%
2009 โ‚น80.08 M-40.56%
2008 โ‚น0.13 B-54.96%
2007 โ‚น0.29 B106.1%
2006 โ‚น0.14 B1012.17%
2005 โ‚น13.05 M
2003 โ‚น43.16 M-20.84%
2002 โ‚น54.52 M-68.78%
2001 โ‚น0.17 B-43.37%
2000 โ‚น0.30 B30.28%
1999 โ‚น0.23 B-18.12%
1998 โ‚น0.28 B0.78%
1997 โ‚น0.28 B50.57%
1996 โ‚น0.19 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
โ‚น0.08 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.612 T 15,759.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น109.30 B 563.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น432.39 B 2,524.33%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚น6.80 B-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA